These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28397375)

  • 1. Elevation of circulating microRNA levels in obese children compared to healthy controls.
    Thompson MD; Cismowski MJ; Serpico M; Pusateri A; Brigstock DR
    Clin Obes; 2017 Aug; 7(4):216-221. PubMed ID: 28397375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of miR-122 and nonalcoholic fatty liver disease in pre-pubertal obese children.
    Brandt S; Roos J; Inzaghi E; Kotnik P; Kovac J; Battelino T; Cianfarani S; Nobili V; Colajacomo M; Kratzer W; Denzer C; Fischer-Posovszky P; Wabitsch M
    Pediatr Obes; 2018 Mar; 13(3):175-182. PubMed ID: 29271122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miRNAs as Biomarkers of Obesity and Obesity-Associated Comorbidities in Children and Adolescents: A Systematic Review.
    Oses M; Margareto Sanchez J; Portillo MP; Aguilera CM; Labayen I
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31783635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
    Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
    PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in circulating microRNA profile of obese children indicates future risk of adult diabetes.
    Cui X; You L; Zhu L; Wang X; Zhou Y; Li Y; Wen J; Xia Y; Wang X; Ji C; Guo X
    Metabolism; 2018 Jan; 78():95-105. PubMed ID: 28966078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum complement factor 5a levels are associated with nonalcoholic fatty liver disease in obese children.
    Hu W; Wang M; Yin C; Li S; Liu Y; Xiao Y
    Acta Paediatr; 2018 Feb; 107(2):322-327. PubMed ID: 28981167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population.
    Pillai SS; Lakhani HV; Zehra M; Wang J; Dilip A; Puri N; O'Hanlon K; Sodhi K
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The investigation of circulating microRNAs associated with lipid metabolism in childhood obesity.
    Can U; Buyukinan M; Yerlikaya FH
    Pediatr Obes; 2016 Jun; 11(3):228-34. PubMed ID: 26223376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in circulating microRNAs are associated with childhood obesity.
    Prats-Puig A; Ortega FJ; Mercader JM; Moreno-Navarrete JM; Moreno M; Bonet N; Ricart W; López-Bermejo A; Fernández-Real JM
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1655-60. PubMed ID: 23928666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease.
    Ustyol A; Aycan Ustyol E; Gurdol F; Kokali F; Bekpınar S
    Scand J Clin Lab Invest; 2017 May; 77(3):205-209. PubMed ID: 28318371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.
    Pirola CJ; Fernández Gianotti T; Castaño GO; Mallardi P; San Martino J; Mora Gonzalez Lopez Ledesma M; Flichman D; Mirshahi F; Sanyal AJ; Sookoian S
    Gut; 2015 May; 64(5):800-12. PubMed ID: 24973316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.
    Becker PP; Rau M; Schmitt J; Malsch C; Hammer C; Bantel H; Müllhaupt B; Geier A
    PLoS One; 2015; 10(11):e0142661. PubMed ID: 26565986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood Obesity Risk in Relationship to Perilipin 1 (
    Görücü Yılmaz Ş; Bozkurt H; Ndadza A; Thomford NE; Karaoğlan M; Keskin M; Benlier N; Dandara C
    OMICS; 2020 Jan; 24(1):43-50. PubMed ID: 31851864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Cai C; Lin Y; Yu C
    Can J Gastroenterol Hepatol; 2019; 2019():2096161. PubMed ID: 31531307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
    Liang S; Cheng X; Hu Y; Song R; Li G
    Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population.
    Ando Y; Yamazaki M; Yamada H; Munetsuna E; Fujii R; Mizuno G; Ichino N; Osakabe K; Sugimoto K; Ishikawa H; Ohashi K; Teradaira R; Ohta Y; Hamajima N; Hashimoto S; Suzuki K
    Sci Rep; 2019 Dec; 9(1):18856. PubMed ID: 31827150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease.
    Tan Y; Ge G; Pan T; Wen D; Gan J
    PLoS One; 2014; 9(8):e105192. PubMed ID: 25141008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease.
    Okamoto K; Koda M; Okamoto T; Onoyama T; Miyoshi K; Kishina M; Matono T; Kato J; Tokunaga S; Sugihara T; Hiramatsu A; Hyogo H; Tobita H; Sato S; Kawanaka M; Hara Y; Hino K; Chayama K; Murawaki Y; Isomoto H
    PLoS One; 2020; 15(2):e0219412. PubMed ID: 32106257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
    Sayın O; Tokgöz Y; Arslan N
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.